About Adicet Bio
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
Leadership at Adicet Bio
The team at the top of the org chart.
Chen Schor
President and CEO
77 reports
Nick Harvey
Chief Financial Officer
4 reports
Don Healey
Chief Technology Officer
3 reports
Blake Aftab
Chief Scientific Officer
51 reports
Amy Locke
Head of Human Resources
3 reports
Julie Maltzman
Chief Medical Officer
6 reports
Jason Chan
Vice President, Quality Assurance
1 report
Simona Costanzo, PhD, PMP
VP, Project Team Leadership
Asher Page
Executive Director, Business Development And Portfolio Strategy
Board
Aya Jakobovits
Founder, Director & Senior Strategic Advisor
Jeffrey A. Chodakewitz
Member Board of Directors
Steve Dubin
Director
Carl L. Gordon
Director
Bastiano Sanna
Director
Andrew Sinclair
Director